Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Liu

Showing results (281-290 of 420) with videos related to

Pageof 42
Sort By:
Biochemical Pharmacology|August 21, 2017
The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5pYinting Chen, Linjuan Zeng, Yong Wang, et al.
Journal of Hematology & Oncology|June 22, 2021
Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumorsJian Li, Yanhong Deng, Weijie Zhang, et al.
Drug Delivery|January 27, 2021
A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liverMarites P Melancon, Steven Yevich, Rony Avritscher, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 17, 2024
Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver MalignancyAndrew S Kennedy, Daniel B Brown, Marwan Fakih, et al.
Contemporary Clinical Trials|April 24, 2024
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trialMatisyahu Shulman, Scott Provost, Kaitlyn Ohrtman, et al.
Journal for Immunotherapy of Cancer|August 29, 2024
Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumabAnna K Maloney, Anita Giobbie-Hurder, Nikita Katukota, et al.
Nature Communications|March 2, 2025
Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomicsShreya Johri, Kevin Bi, Breanna M Titchen, et al.
Frontiers in Surgery|June 11, 2024
The effect of an intraoperative patient-specific, surgery-specific haemodynamic algorithm in improving textbook outcomes for hepatobiliary-pancreatic surgery: a multicentre retrospective studyBradly Carp, Laurence Weinberg, Luke R Fletcher, et al.
Infectious Diseases and Therapy|January 14, 2024
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal AntibodiesNorman Moullan, Josephat Asiago, Kathryn Stecco, et al.
American Journal of Clinical Oncology|June 6, 2008
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patientsAndrew S Kennedy, William A Dezarn, Patrick McNeillie, et al.
Pageof 42

Showing results (281-290 of 420) with videos related to

Sort By:
Pageof 42
Biochemical Pharmacology|August 21, 2017
The expression, induction and pharmacological activity of CYP1A2 are post-transcriptionally regulated by microRNA hsa-miR-132-5pYinting Chen, Linjuan Zeng, Yong Wang, et al.
Journal of Hematology & Oncology|June 22, 2021
Subcutaneous envafolimab monotherapy in patients with advanced defective mismatch repair/microsatellite instability high solid tumorsJian Li, Yanhong Deng, Weijie Zhang, et al.
Drug Delivery|January 27, 2021
A novel irinotecan-lipiodol nanoemulsion for intravascular administration: pharmacokinetics and biodistribution in the normal and tumor bearing rat liverMarites P Melancon, Steven Yevich, Rony Avritscher, et al.
Journal of Vascular and Interventional Radiology : JVIR|June 17, 2024
Multidisciplinary Delphi Consensus on Safety of Combining Transarterial Radioembolization with Yttrium-90 Microspheres with Systemic Anticancer Agents for the Treatment of Liver MalignancyAndrew S Kennedy, Daniel B Brown, Marwan Fakih, et al.
Contemporary Clinical Trials|April 24, 2024
Discontinuation of medication treatment for opioid use disorder after a successful course: The discontinuation phase of the CTN-0100 (RDD) trialMatisyahu Shulman, Scott Provost, Kaitlyn Ohrtman, et al.
Journal for Immunotherapy of Cancer|August 29, 2024
Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumabAnna K Maloney, Anita Giobbie-Hurder, Nikita Katukota, et al.
Nature Communications|March 2, 2025
Dissecting tumor cell programs through group biology estimation in clinical single-cell transcriptomicsShreya Johri, Kevin Bi, Breanna M Titchen, et al.
Frontiers in Surgery|June 11, 2024
The effect of an intraoperative patient-specific, surgery-specific haemodynamic algorithm in improving textbook outcomes for hepatobiliary-pancreatic surgery: a multicentre retrospective studyBradly Carp, Laurence Weinberg, Luke R Fletcher, et al.
Infectious Diseases and Therapy|January 14, 2024
A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal AntibodiesNorman Moullan, Josephat Asiago, Kathryn Stecco, et al.
American Journal of Clinical Oncology|June 6, 2008
Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patientsAndrew S Kennedy, William A Dezarn, Patrick McNeillie, et al.
Pageof 42